Condition
Recurrent Breast Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Recurrent Breast Carcinoma clinical trials that are recruiting, at sites in 6 countries (most in United States (5), Puerto Rico (1), Saudi Arabia (1)). By phase: Phase 2 (2), Phase 1 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 6Countries
Newest Recurrent Breast Carcinoma clinical trials
All recruiting trials (7)
-
Breast-preserving treatment using repeat radiation for recurrent breast cancer
The trial will try breast-conserving surgery plus repeat radiation to see if people 55 or older with a small, local recurrent breast cancer can safely keep their breast instead of having a mastectomy.
-
Single-dose preoperative radiotherapy and repeat breast surgery for recurrent breast cancer
This study is testing if a single dose of targeted radiation before surgery can help older patients with recurring breast cancer have better treatment results and improve their appearance after surgery.
-
Personalized tumor vaccine with checkpoint inhibitors for triple negative breast cancer
This phase I trial will test whether a personalized tumor membrane vesicle (TMV) vaccine, given alone or with pembrolizumab or ipilimumab, can boost immune response and help control disease in adults with triple negative breast cancer.
-
Collecting samples and data from patients with recurrent or metastatic breast cancer
This study is collecting blood and tissue samples from patients with recurrent or metastatic breast cancer to learn more about the disease and improve treatment options.
-
Lutetium-177 DOTATATE for Stage IV or Recurrent Breast Cancer
This study tests whether 177Lu-DOTATATE can shrink or slow the growth of breast cancer that has spread or come back in patients whose tumors express SSTR2.
-
A vaccine using modified measles virus for treating metastatic breast cancer
This study is testing a modified measles virus vaccine to see if it can safely help people with metastatic breast cancer by shrinking their tumors.
-
Using carvedilol to prevent heart problems in patients with advanced HER-2-positive breast cancer
This study is testing if the heart medication carvedilol can help prevent heart problems in patients with advanced HER-2-positive breast cancer who are being treated with trastuzumab.
Related topics
Quick answers
How many Recurrent Breast Carcinoma clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (5 trials), Puerto Rico (1 trial), Saudi Arabia (1 trial), South Korea (1 trial), Finland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.